Nevertheless, the MR-Egger intercept showed no evidence of directional pleiotropy and the MR estimates from additional sensitivity analyses were consistent with the null finding, meaning that considerable bias due to pleiotropy is unlikely
Any dosing figures below describe clinical-trial protocols or, for cagrilintide, research conventions with no approved label not a personal protocol
The medicinal-chemistry programme that produced cagrilintide, described by Kruse and colleagues in the Journal of Medicinal Chemistry in 2021, addressed this by re-engineering the amylin backbone with structural elements borrowed from calcitonin (a related, non-aggregating peptide) and attaching a fatty-acid side chain that enables reversible binding to serum albumin [1]
Also known as 5 amino 1 methylquinolinium, its structure has made it a subject of interest for investigating NNMT activity and related cellular metabolic pathways
These changes were partially moderated by changes in brain morphometry, underscoring the interrelationship between weight and brain structure/ function